Penn Valley, PA, United States of America

Mark I Greene

This inventor holds 72 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Antibody Therapeutics (CPC class A61K). Top assignees: University of Pennsylvania, Cephalon, Inc., Colorado State University Research Foundation. Active years: 1993-2025.

USPTO Granted Patents = 72 (Patent Applications = 18)

% Patents Active = 76.4

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 18

Forward Citations = 928(Granted Patents)

Forward Citations (Not Self Cited) = 813(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

71 out of 2,645

University of Pennsylvania

Colorado State University Research Foundation

patents

4. 1 out of 299

The Children's Hospital of Philadelphia

University of Illinois

patents

7. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

Anti-Platelet Antibodies

Cancer Radiation Therapy

Tumor Necrosis Factor

Peptidomimetics

Immune Complex

Monoclonal Antibodies

Bifunctional Enzymes

Immunodetection Reagents

Autoimmune Colitis

EGFR Kinase Domain

HER2/neu Receptor

Antigen-Binding Proteins

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12304948 - Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia (2025-05-20),

2. 12282028 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2025-04-21),

3. 11913963 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2024-02-27),

4. 11524999 - Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia (2022-12-13),

5. 11446516 - Methods of increasing response to cancer radiation therapy (2022-09-20),

6. 11435362 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2022-09-06),

7. 11312784 - IgG binding peptides and multifunctional antigen-binding proteins comprising the same (2022-04-26),

8. 10583166 - Antigen-binding proteins comprising recombinant protein scaffolds (2020-03-10),

9. 10371705 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2019-08-06),

10. 9751830 - Inhibitors of the tumor necrosis factor receptor complex (2017-09-05),

11. 9701631 - TIP60 inhibitors (2017-07-11),

12. 9695252 - Antigen-binding proteins comprising recombinant protein scaffolds (2017-07-04),

13. 9321759 - Methods and use of bifunctional enzyme-building clamp-shaped molecules (2016-04-26),

14. 9295676 - Mutation mimicking compounds that bind to the kinase domain of EGFR (2016-03-29),

15. 9265739 - Methods and use of compounds that bind to HER2/neu receptor complex (2016-02-23),

Title: The Innovative Journey of Mark I Greene

Introduction: Mark I Greene, a visionary inventor based in Penn Valley, PA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Mark I Greene holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Mark I Greene has been at the forefront of innovation, leading research and development teams to create cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Mark I Greene has collaborated with leading universities, research institutions, and tech companies to bring his inventions to life. His collaborative spirit has led to the successful implementation of groundbreaking technologies.

Conclusion: Mark I Greene's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.